Article
Covalent inhibition of the SARS-CoV-2 NiRAN domain via an active-site cysteine
medRxiv · 2024 · Hernandez, G.; Osinski, A.; Majumdar, A.; Eitson, J. L.; Antczak, M.; Pawlowski, K.; Niederstrasser, H.; Servage, K. A.; Posner, B.; Schoggins, J. W.; Ready, J. A.; Tagliabracci, V. S.
Key facts
| Title | Covalent inhibition of the SARS-CoV-2 NiRAN domain via an active-site cysteine |
|---|---|
| First author | Hernandez, G.; Osinski, A.; Majumdar, A.; Eitson, J. L.; Antczak, M.; Pawlowski, K.; Niederstrasser, H.; Servage, K. A.; Posner, B.; Schoggins, J. W.; Ready, J. A.; Tagliabracci, V. S. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.11.22.624893 |
| Product codes mentioned | KDT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1